# Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI

> **NCT02841397** · — · COMPLETED · sponsor: **Masimo Corporation** · enrollment: 50 (actual)

## Conditions studied

- Surgery

## Interventions

- **DEVICE:** Masimo Pulse CO-Oximeter

## Key facts

- **NCT ID:** NCT02841397
- **Lead sponsor:** Masimo Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-09
- **Primary completion:** 2017-10-11
- **Final completion:** 2017-10-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02841397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02841397, "Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02841397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*